The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes
暂无分享,去创建一个
R. Dahl | A. Anzueto | P. Calverley | Wenbo Tang | R. Wise | D. Dusser | N. Metzdorf
[1] G. Pledger,et al. Tiotropium Respimat inhaler and the risk of death in COPD. , 2013, The New England journal of medicine.
[2] G. Pledger,et al. The Tiotropium Safety and Performance in Respimat (TIOSPIR) trial: Bronchodilator efficacy in a spirometry substudy , 2013 .
[3] G. Pledger,et al. The Tiotropium Safety and Performance in Respimat® Trial (TIOSPIR®), a large scale, randomized, controlled, parallel-group trial-design and rationale , 2013, Respiratory Research.
[4] C. Tantucci,et al. Lung function decline in COPD , 2012, International journal of chronic obstructive pulmonary disease.
[5] L. Edwards,et al. Changes in forced expiratory volume in 1 second over time in COPD. , 2011, The New England journal of medicine.
[6] E. Bateman,et al. A one-year trial of tiotropium Respimat plus usual therapy in COPD patients. , 2010, Respiratory medicine.
[7] M. Decramer,et al. Treatment of COPD: the sooner the better? , 2010, Thorax.
[8] E. Bateman,et al. International Journal of Copd Dovepress Dovepress Efficacy and Safety of Tiotropium Respimat ® Smi in Copd in Two 1-year Randomized Studies , 2022 .
[9] M. Decramer,et al. Cardiovascular safety of tiotropium in patients with COPD. , 2010, Chest.
[10] M. Decramer,et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.
[11] M. Decramer,et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.
[12] P. Calverley,et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. , 2008, American journal of respiratory and critical care medicine.
[13] Yahong Peng,et al. Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials , 2008 .
[14] A. Anzueto,et al. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. , 2005, Pulmonary pharmacology & therapeutics.
[15] Nicholas J Gross,et al. Tiotropium Bromide , 2012 .
[16] R. Zuwallack,et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.
[17] R. Casaburi,et al. Tiotropium bromide. Commentaries , 2002 .
[18] J E Cotes,et al. Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.
[19] J E Cotes,et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.
[20] R. Peto,et al. The natural history of chronic airflow obstruction. , 1977, British medical journal.